Equities

Bruker Corp

Bruker Corp

Actions
Health CareMedical Equipment and Services
  • Price (USD)56.89
  • Today's Change0.665 / 1.18%
  • Shares traded1.46m
  • 1 Year change-12.55%
  • Beta1.1776
Data delayed at least 15 minutes, as of Nov 22 2024 20:49 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments4886461,168
Total Receivables, Net492473417
Total Inventory968800710
Prepaid expenses------
Other current assets, total216195177
Total current assets2,1642,1132,472
Property, plant & equipment, net691538466
Goodwill, net583458340
Intangibles, net331271212
Long term investments------
Note receivable - long term------
Other long term assets18415571
Total assets4,2503,6123,650
LIABILITIES
Accounts payable203178147
Accrued expenses239195--
Notes payable/short-term debt000
Current portion long-term debt/capital leases12119112
Other current liabilities, total639522679
Total current liabilities1,202914939
Total long term debt1,1601,2011,222
Total debt1,2821,2191,334
Deferred income tax686246
Minority interest361814
Other liabilities, total407303359
Total liabilities2,8732,4982,580
SHAREHOLDERS EQUITY
Common stock1.701.701.70
Additional paid-in capital283256238
Retained earnings (accumulated deficit)2,3241,9261,660
Treasury stock - common(1237)(1085)(820)
Unrealized gain (loss)------
Other equity, total6.0015(8.2)
Total equity1,3771,1141,071
Total liabilities & shareholders' equity4,2503,6123,650
Total common shares outstanding145147151
Treasury shares - common primary issue312824
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.